Oklahoma AG makes deal to return state’s stockpile of failed COVID-19 medication hydroxychloroquine

OKLAHOMA CITY — Oklahoma’s collection of the failed COVID-19 medication hydroxychloroquine is headed back after Attorney General Mike Hunter struck a deal with the seller, Hunter’s office announced Friday.

The state bought 1.2 million hydroxychloroquine pills in April 2020 from California-based supplier FFF Enterprises as Gov. Kevin Stitt and the state health department followed the lead of former President Donald Trump who touted the drug’s possible effectiveness.

Hydroxychloroquine has since been shown to have little or no effect on severe cases of COVID-19, and a former state health official chalked up Oklahoma’s purchase to something that happens in “the fog of war.”

Hunter says Friday’s deal will return the state’s stockpile for a full refund.

“I commend the leadership at FFF Enterprises who worked with us to return the state’s supply of hydroxychloroquine while giving the state a refund,” Hunter says in a press release.

“They recognized we were in competition with every other state in the nation to get whatever we could to protect Oklahomans. When it was determined the drug wasn’t effective in combatting the virus, they did the right thing by refunding our money. FFF is the type of company that Oklahoma likes to do business with, and we appreciate their partnership.”

>> Read the full agreement here.

Governments in at least 20 other states obtained more than 30 million doses of the drug through donations from the federal reserve or private companies, however Oklahoma and Utah bought them from private pharmaceutical companies, according to the Associated Press.

The Associated Press contributed to this report.